CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-07 | Kaplin Adam Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-04-04 | Chapman Christopher C JR President, Chief Med. Officer | Grant or award · Employee Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2022-12-08 | Rivard Paul EVP of Operations, GC | Purchase | +10,000 | $1.53 | $15K | 225,000 |
| 2021-11-26 | Silverman Joshua Director | Purchase | +5,000 | $7.55 | $38K | 88,775 |
| 2021-11-24 | Silverman Joshua Director | Purchase | +6,734 | $6.30 | $42K | 80,509 |
| 2021-11-24 | Silverman Joshua Director | Purchase | +3,266 | $7.09 | $23K | 83,775 |
| 2021-11-23 | Rivard Paul EVP of Operations, GC | Purchase | +15,000 | $6.03 | $90K | 215,000 |
| 2021-10-14 | Kaplin Adam Chief Scientific Officer | Grant or award · Restricted Stock Units | +600,000 | 600,000 | ||
| 2021-10-14 | Schreiber Christopher C Director | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2021-10-14 | White Billy Joe Director | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2021-10-14 | Uzonwanne Jude Director | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2021-10-14 | EAGLE CRAIG Director | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2021-10-14 | Silverman Joshua Director | Grant or award · Restricted Stock Units | +600,000 | 600,000 | ||
| 2021-10-14 | Chapman Christopher C JR President, Chief Med. Officer | Grant or award · Restricted Stock Units | +600,000 | 600,000 | ||
| 2021-10-14 | Rivard Paul EVP of Operations, GC | Grant or award · Restricted Stock Units | +200,000 | 200,000 | ||
| 2021-04-16 | EAGLE CRAIG Director | Grant or award · Stock Option (Right to Buy) | +482,375 | 482,375 | ||
| 2021-04-16 | Kaplin Adam Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +154,360 | 154,360 | ||
| 2021-04-16 | Schreiber Christopher C Director | Option exercise | +131,750 | 134,351 | ||
| 2021-04-16 | Schreiber Christopher C Director | Shares withheld for taxes | −46,113 | $4.94 | $228K | 88,238 |
| 2021-04-16 | Schreiber Christopher C Director | Option exercise · Restricted Stock Units | −131,750 | 0 |
Page 3 of 8 · 142 trades